Lv1
50 积分 2025-07-24 加入
In vivo genome editing of human haematopoietic stem cells for treatment of blood disorders using mRNA delivery
17小时前
待确认
Biotech's Coming of Age
18小时前
已完结
Novel drug targets in 2025
18小时前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
18天前
已完结
Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapy
1个月前
已完结
Engineered Stem Cells Provide Cancer-Killing iNKT Cells
1个月前
已完结
In vivo CAR T purchase spree continues with Lilly deal worth up to US$7 billion
1个月前
已关闭
Target identification and assessment in the era of AI
1个月前
已完结
Biologic degraders push forward in the clinic
1个月前
已完结
皖公网安备34019202002308
